Raphael Pharmaceutical (RAPH) Intangibles (2022 - 2024)
Raphael Pharmaceutical's (RAPH) quarterly Intangibles came in at $2000.0 in Q2 2024, up 100.0% year-over-year from $1000.0 in Q3 2023, and down 33.33% quarter-over-quarter from $3000.0 in Q1 2024.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Intangibles (2022 - 2024) Analysis & Trends
Raphael Pharmaceutical has disclosed Intangibles across 3 years of filings, most recently posting $2000.0 for Q2 2024.
- In Q2 2024, Intangibles rose 100.0% year-over-year to $2000.0; the TTM figure through Jun 2024 stood at $2000.0 (up 100.0% YoY), while the FY2023 annual figure was $2000.0, changed 0.0% from the prior year.
- Intangibles came in at $2000.0 for Q2 2024 at Raphael Pharmaceutical, down from $3000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $3000.0 in Q1 2024 to a low of $1000.0 in Q1 2023.
- Average Intangibles over 3 years is $1750.0, with a median of $2000.0 recorded in 2022.
- Year-over-year, Intangibles tumbled 50.0% in 2023 and soared 200.0% in 2024.
- Over 3 years, Intangibles stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024.
- Per Business Quant data, the three most recent Intangibles figures were $2000.0 in Q2 2024, $3000.0 in Q1 2024, and $2000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 20.49 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 14.03 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 412.80 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 1.31 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 266.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 13.52 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |